In-hospital delays to stroke thrombolysis: Paradoxical effect of early arrival

Neurological Research

Volumn 29, Issue 7, 2007, Pages 664-666

  Romano, Jose G ^a   Muller, Nils ^a   Merino, Jose G ^b   Forteza, Alejandro M ^a   Koch, Sebastian ^a   Rabinstein, Alejandro A ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Acute therapy; Intravenous thrombolysis; Stroke

Indexed keywords

ANTIHYPERTENSIVE AGENT; DILTIAZEM; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE SEVERITY; HEART ATRIUM FIBRILLATION; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; STROKE; THERAPY DELAY;

ACADEMIC MEDICAL CENTERS; AGED; AGED, 80 AND OVER; DRUG UTILIZATION REVIEW; EMERGENCY SERVICE, HOSPITAL; EMERGENCY TREATMENT; FIBRINOLYTIC AGENTS; HOSPITALIZATION; HUMANS; INFUSIONS, INTRAVENOUS; MEDICAL AUDIT; MIDDLE AGED; QUALITY OF HEALTH CARE; RETROSPECTIVE STUDIES; STROKE; THROMBOLYTIC THERAPY; TIME AND MOTION STUDIES; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TRANSPORTATION OF PATIENTS; TRIAGE;

EID: 36049048348     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164107X240035     Document Type: Article

References (10)

1. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995; 331: 1581-1588
2. Katzan IL, Furlan AJ, Lloyd LE, et al. Use of tissue-type plasminogen activator for acute ischemic stroke: The Cleveland area experience. JAMA 2000; 283: 1151-1158
3. Marler JR, Tilley BC, Lu M, et al. Early stroke treatment associated with better outcome: The NINDS rt-PA Stroke Study. Neurology 2000; 55: 1649-1655
4. Albers GW, Bates VE, Clark WM, et al. Intravenous tissue-type plasminogen activator for treatment of acute stroke: The Standard Treatment with Alteplase to Reverse Stroke (STARS) Study. JAMA 2000; 283: 1145-1150
5. Merino JG, Silver B, Wong E, et al. Extending tissue plasminogen activator use to community and rural stroke patients. Stroke 2002; 33: 141-146
6. Chui D, Krieger D, Villar-Cordova C, et al. Intravenous tissue plasminogen activator for acute ischemic stroke: Feasibility, safety and efficacy in the first year of clinical practice. Stroke 1998; 29: 18-22
7. Morris DL, Rosamond W, Madden K, et al. Prehospital and Emergency Department delays after acute stroke. The Genentech Stroke Presentation Survey. Stroke 2000; 31: 2585-2590
8. Wester P, Radberg J, Lundgrn B, et al. Factors associated with delayed admission to hospital and in-hospital delays in acute stroke and TIA. Stroke 1999; 30: 40-48
9. Smith M, Doliszny K, Shahar E, et al. Delayed hospital arrival for acute stroke: The Minnesota Stroke Survey. Ann Intern Med 1998; 129: 18-22
10. Evenson KR, Rosamond WD, Morris DL. Prehospital and inhospital delays in acute stroke care. Neuroepidemiology 2001; 20: 65-76